| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.07 |